Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 22, Issue 7, Pages 881-894
Publisher
Informa Healthcare
Online
2013-05-03
DOI
10.1517/13543784.2013.795945
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
- (2013) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- Cognitive Functioning in Prodromal Psychosis
- (2012) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Increased Stress-Induced Dopamine Release in Psychosis
- (2012) Romina Mizrahi et al. BIOLOGICAL PSYCHIATRY
- COMT Val158Met Genotype Determines the Direction of Cognitive Effects Produced by Catechol-O-Methyltransferase Inhibition
- (2012) Sarah M. Farrell et al. BIOLOGICAL PSYCHIATRY
- A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D2 receptor antagonist in the treatment of acute exacerbation of schizophrenia
- (2012) Mark E. Schmidt et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The use of lisdexamfetamine dimesylate for the treatment of ADHD
- (2012) Ann C Childress et al. Expert Review of Neurotherapeutics
- BL-1020, a New γ-Aminobutyric Acid–Enhanced Antipsychotic
- (2012) Yona Geffen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Poster #175 ADJUNCTIVE LISDEXAMFETAMINE DIMESYLATE TREATMENTOF PREDOMINANT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN CLINICALLY STABLE ADULTS MAINTAINED ON ATYPICAL ANTIPSYCHOTIC AGENTS: A 14-WEEK TRIAL
- (2012) Robert Lasser et al. SCHIZOPHRENIA RESEARCH
- Diverse Facets of COMT: From a Plausible Predictive Marker to a Potential Drug Target for Schizophrenia
- (2011) M. Gupta et al. CURRENT MOLECULAR MEDICINE
- P03-185 - The efficacy and safety of the novel antipsychotic cariprazine in acute exacerbation of schizophrenia
- (2011) A. Bose et al. EUROPEAN PSYCHIATRY
- Tetrabenazine Augmentation in Treatment-Resistant Schizophrenia
- (2011) Gary Remington et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Contribution of SPECT Measurements of D2 and 5-HT2A Occupancy to the Clinical Development of the Antipsychotic SB-773812
- (2011) A. M. Catafau et al. JOURNAL OF NUCLEAR MEDICINE
- Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112
- (2011) Anissa Abi-Dargham et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
- (2011) O Howes et al. MOLECULAR PSYCHIATRY
- Striatal dopamine synthesis capacity in twins discordant for schizophrenia
- (2011) P. Shotbolt et al. PSYCHOLOGICAL MEDICINE
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures
- (2010) Mark J. Millan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: Results from an aborted randomised trial
- (2010) Geartsje Boonstra et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- The EPPIC Follow-Up Study of First-Episode Psychosis
- (2010) Lisa P. Henry et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pergolide Treatment of Cognitive Deficits Associated with Schizotypal Personality Disorder: Continued Evidence of the Importance of the Dopamine System in the Schizophrenia Spectrum
- (2010) Margaret M McClure et al. NEUROPSYCHOPHARMACOLOGY
- Antipsychotic Dosing: How Much but also How Often?
- (2010) G. Remington et al. SCHIZOPHRENIA BULLETIN
- ITI-007: A NOVEL THERAPY FOR THE TREATMENT OF SCHIZOPHRENIA AND RELATED PSYCHOSES
- (2010) Kimberly E. Vanover et al. SCHIZOPHRENIA RESEARCH
- Cognitive and symptomatic predictors of functional disability in schizophrenia
- (2010) Syed Shamsi et al. SCHIZOPHRENIA RESEARCH
- Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
- (2010) Pennick Neuropsychiatric Disease and Treatment
- The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors
- (2009) Ariel Graff-Guerrero et al. ARCHIVES OF GENERAL PSYCHIATRY
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
- (2009) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Tolcapone Effects on Gating, Working Memory, and Mood Interact with the Synonymous Catechol-O-methyltransferase rs4818C/G Polymorphism
- (2009) Panos Roussos et al. BIOLOGICAL PSYCHIATRY
- Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects
- (2009) Anissa Abi-Dargham et al. BIOLOGICAL PSYCHIATRY
- Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy
- (2009) Ilya A Lipkovich et al. BMC Psychiatry
- Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I
- (2009) R. Miller Current Neuropharmacology
- Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II
- (2009) R. Miller Current Neuropharmacology
- Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancingN-methyl-D-aspartate receptor-mediated synaptic strength
- (2009) Gang Lei et al. JOURNAL OF NEUROCHEMISTRY
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
- (2009) Maria C Rodriguez-Oroz et al. LANCET NEUROLOGY
- L-Dopa Medication in Parkinson's Disease Restores Activity in the Motor Cortico-Striatal Loop but Does Not Modify the Cognitive Network
- (2009) Thomas Jubault et al. PLoS One
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Toward a Terminology for Functional Recovery in Schizophrenia: Is Functional Remission a Viable Concept?
- (2009) P. D. Harvey et al. SCHIZOPHRENIA BULLETIN
- Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis
- (2009) Joseph Ventura et al. SCHIZOPHRENIA RESEARCH
- Premorbid IQ in Schizophrenia: A Meta-Analytic Review
- (2008) Kristen A. Woodberry et al. AMERICAN JOURNAL OF PSYCHIATRY
- Longitudinal studies of cognition in schizophrenia: Meta-analysis
- (2008) Andrei Szöke et al. BRITISH JOURNAL OF PSYCHIATRY
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- Is executive impairment associated with schizophrenic syndromes? A meta-analysis
- (2008) C. R. M. Dibben et al. PSYCHOLOGICAL MEDICINE
- Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
- (2008) Daniel E. Casey et al. PSYCHOPHARMACOLOGY
- The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist
- (2008) Sridhar Natesan et al. PSYCHOPHARMACOLOGY
- Regional dopamine synthesis in patients with schizophrenia using L-[β-11C]DOPA PET
- (2008) Shoko Nozaki et al. SCHIZOPHRENIA RESEARCH
- Striatal Dopamine Synthesis in First-degree Relatives of Patients with Schizophrenia
- (2007) Jukka Huttunen et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started